MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'ifpma'. Sat, 03 Sep 2011 02:59:09 +0100 http://www.medworm.com/index.php?rid=4615426&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FPl4PHiJPh2U%2F Over the past week, a note has been circulating on the Internet about the web site that Eli Lilly created for its Strattera ADHD medication for consumers in China. Specifically, the missive points out that the Strattera site offers very different info about the risks and benefits of the medication. As an example, the US Strattera site warns patients of suicide risk, but not the Chinese site. “Lilly’s web site in China says nothing about this risk; patients are told nothing about any Strattera side effects at all. Chinese readers are warned instead about the dangers of ADHD (deliquency, substance abuse, unemployment, depression and other serious problems, both personal and social) unless treated with medication,” according to the note that was distributed by Ben Hansen, a ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4615426 Mon, 21 Mar 2011 14:42:06 +0100 4615426 http://www.medworm.com/index.php?rid=4460185&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FcHs7oSEPblk%2F Good morning, everyone, and nice to see you again. Yet another deep freeze has descended on the Pharmalot corporate campus, but we manage to keep warm with our mandatory cup of stimulation and stimulating news. On that note, we offer you a smattering of tidbits to get you started. We hope your day goes well and your goals are accomplished. Have a good one… Novartis Moves To Prevent Execution Drug From Reaching US (Reuters) Botox Use For Migraines Is Questioned (BBC News) Novartis And Pfizer Drugs Boost Lung Function In COPD Patients (Reuters) Medical Device Makers Shun The US (New York Times) J&J Negotiates Hip Replacements With Lawyers (Bloomberg News) Black Rock To Provide Data Merck Wants For Vytorin Defense (Dow Jones) Shire Pharma Earnings Match Expectations (Reuters) IFPMA... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4460185 Thu, 10 Feb 2011 13:09:18 +0100 4460185 http://www.medworm.com/index.php?rid=3858382&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F80EA963DpmU%2F Now that the World Health Organization has officially declared that the swine flu pandemic is over (see this), the agency has finally released the names of the scientific advisors who helped with pandemic decisions and their declared conflicts of interest, such as paid work for drugmakers. The move comes four months after the WHO denied the pharmaceutical industry had undue influence over its decisions about the extent of the pandemic and two months after the Council of Europe issued a report harshly criticizing the agency’s lack of transparency around the handling of the swine flu pandemic (back story here and here). For its part, the WHO called the accusations “conspiracy theories,” but refused to release the conflict of interest forms filed by the 16 members of its eme... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3858382 Wed, 11 Aug 2010 11:45:32 +0100 3858382 http://www.medworm.com/index.php?rid=3672036&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FXG8ViSrcrXA%2F Rise and shine. Another day is on the way. Hello, everyone, hope all is well as you gear up for those meetings and deadlines. We can relate. To cope, we are brewing the mandatory cup of stimulation. Feel free to indulge yourself, or grab a water bottle if you prefer. Meanwhile, here are a few items to help you get started. Have a good one and stay in touch… Pay For Delays Deals Nearing A Turning Point? (Bloomberg News) FDA To Decide On Orexigen Obesity Pill In January (Reuters) Merck To Cut 800 Jobs In France (La Tribune) Merck KGgA Resumes Vaccine Trial For Lung Cancer (Reuters) UK’s NICE Refuses To Cover Roche’s Tarceva (PharmaTimes) Medicare To Review Coverage Of Anemia Drugs (Reuters) AstraZeneca May Fight Canadian Court Ruling On Nexium Generic (Bloomberg) Industry G... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3672036 Thu, 17 Jun 2010 11:55:27 +0100 3672036 http://www.medworm.com/index.php?rid=3096855&cid=t_141958_87_f&fid=38368&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FDisruptiveWomenInHealthCare%2F%7E3%2Fbcq6qZOsmlU%2F The following guest post by Susan Crowley, President of Multilateral Consulting, LLC, is part of Disruptive Women’s “The Value of Health: Creating Economic Security in the Developing World” series. By any measure, giving programs directed at developing countries by research-based pharmaceutical companies are the most generous of any industry. The Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), whose methodology and data presented in its most recent “Partnerships Report” were validated by the London School of Economics, reported $6.7 billion in giving. The 2009 “Index on Global Philanthropy,” published by the Hudson Institute, provides a measure of global private giving and, once again, demonstrates that private flows... Disruptive Women in Health Care blogs http://www.medworm.com/rss/comments.php?id=3096855 Wed, 16 Dec 2009 14:23:47 +0100 3096855 http://www.medworm.com/index.php?rid=3071458&cid=t_141958_150_f&fid=34768&url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2009%2F12%2Fpsst-this-is-secret-ok.html Don't tell a soul! (Source: PharmaGossip) PharmaGossip blogs http://www.medworm.com/rss/comments.php?id=3071458 Wed, 09 Dec 2009 10:16:00 +0100 3071458 http://www.medworm.com/index.php?rid=2989408&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FA-XPZsFcYF8%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is something that may become a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Irwin Lerner, a former chief executive officer of Roche’s U.S. pharma biz and most recently interim ceo at Medarex, will be among three inductees into the Medical Advertising Hall of Fame for 2010. ImmunoGen named ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2989408 Fri, 13 Nov 2009 13:05:14 +0100 2989408 http://www.medworm.com/index.php?rid=816799&cid=t_141958_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F146966503%2F Last month, some advocacy groups wrote the ceo of each drugmaker, along with PhRMA and the International Federation of Pharmaceutical Manufacturers Associations, urging them to disclose their global contributions. The reason? Concern that donations result in off-label marketing by groups receiving funds; mask the agendas of public policy groups that debate policy issues, and allow researchers to circumvent normal disclosure requirements. In doing so, they cited Lilly’s recent decision to make disclosures, at least in the US. Since then, Lilly agreed to expand its disclosure policy on a global basis. However, Harvey Bale, who heads the IFPMA, wrote back and politely declined to join the bandwagon, saying that disclosures would be a burden and, instead, should be made on a national level. ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=816799 Wed, 22 Aug 2007 16:15:20 +0100 816799